Skip to main content
Clinical Trials/JPRN-UMIN000038169
JPRN-UMIN000038169
Recruiting
未知

Prospective study on the identification of predictors of efficacy and efficacy/safety of twice-daily inhalers with three components in clinical practice for COPD patients (J-BRAVE) - J-BRAVE

Japanese Red Cross Medical Canter0 sites100 target enrollmentOctober 1, 2019
ConditionsCOPD ACO

Overview

Phase
未知
Intervention
Not specified
Conditions
COPD ACO
Sponsor
Japanese Red Cross Medical Canter
Enrollment
100
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 1, 2019
End Date
December 31, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Japanese Red Cross Medical Canter

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients who have previously been treated with Breztri 2\) Patients with serious complications such as heart disease / liver disease / renal disorder 3\) Other patients who are judged to be inappropriate as a target by the doctor's judgment

Outcomes

Primary Outcomes

Not specified

Similar Trials